Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.36 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.35 |
| ▸ | RORC | P51449 | 6/20 | 0.34 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14049778 | 0.90 | NR1H4 (0.40) | HSD17B10TDP1NR1H4TRPV1RORC | |
| SCHEMBL14049851 | 0.89 | NR1H4 (0.41) | HSD17B10TDP1NR1H4RORCPTPN1 | |
| SCHEMBL14049665 | 0.88 | NR1H4 (0.37) | HSD17B10TDP1NR1H4TRPV1RORC | |
| SCHEMBL14049973 | 0.87 | PTPN1 (0.39) | HSD17B10TDP1NR1H4TRPV1RORC | |
| SCHEMBL14049871 | 0.86 | NR1H4 (0.41) | HSD17B10TDP1NR1H4TRPV1RORC | |
| SCHEMBL14049834 | 0.86 | RORC (0.36) | HSD17B10TDP1NR1H4TRPV1RORC | |
| SCHEMBL14049777 | 0.86 | NR1H4 (0.36) | HSD17B10TDP1NR1H4TRPV1RORC | |
| SCHEMBL14049664 | 0.86 | PTPN1 (0.40) | HSD17B10TDP1NR1H4TRPV1RORC | |
| SCHEMBL14049779 | 0.86 | NR1H4 (0.41) | HSD17B10TDP1NR1H4TRPV1RORC | |
| SCHEMBL14049659 | 0.86 | NR1H4 (0.38) | HSD17B10TDP1NR1H4TRPV1RORC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008127364-A2 | ANTIVIRAL COMPOUNDS AND USE THEREOF | MYRIAD GENETICS, INC. (US) | 2008-10-23 | — | — | WO | disclosed |